MetaADEDB 2.0 @ LMMD
Levobunolol
(DNTDOBSIBZKFCP-YDALLXLXSA-N)
Structure
SMILES
O[C@H](COc1cccc2c1CCCC2=O)CNC(C)(C)C.Cl
Molecular Formula:
C17H26ClNO3
Molecular Weight:
327.846
Log P:
3.5263
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
3
TPSA:
58.56
CAS Number(s):
27912-14-7
Synonym(s)
1.
Levobunolol
2.
AKBeta
3.
Apo-Levobunolol
4.
Betagan
5.
Levobunolol Hydrochloride
6.
Novo-Levobunolol
7.
PMS-Levobunolol
8.
Ultracortenol
9.
Vistagan
10.
W-7000A
11.
ratio-Levobunolol
12.
Apo Levobunolol
13.
ApoLevobunolol
14.
Novo Levobunolol
15.
NovoLevobunolol
16.
PMS Levobunolol
17.
PMSLevobunolol
18.
W 7000A
19.
W7000A
20.
ratio Levobunolol
External Link(s)
MeSHD002040
PubChem Compound5284409
441415
67108273
ChEBI6439
CHEMBLCHEMBL1201177
KEGGdr:D01025
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 3
Canada Vigilance: 2		Canada Vigilance
US FAERS
2PalpitationsFAERS: 2US FAERS
3Product quality issueFAERS: 2US FAERS
4Burning sensationFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
5DiscomfortFAERS: 1US FAERS
6Eye painFAERS: 1US FAERS
7Eyelid margin crustingFAERS: 1US FAERS
8Foreign body sensation in eyesFAERS: 1US FAERS
9HeadacheFAERS: 1US FAERS
10Incorrect product storageFAERS: 1US FAERS
11Instillation site discomfortFAERS: 1US FAERS
12Instillation site drynessFAERS: 1US FAERS
13Instillation site erythemaFAERS: 1US FAERS
14Instillation site irritationFAERS: 1US FAERS
15Instillation site painFAERS: 1US FAERS
16PainFAERS: 1US FAERS
17Product package associated injuryFAERS: 1US FAERS
18ScabFAERS: 1US FAERS
19Skin WrinklingFAERS: 1US FAERS
20SyncopeFAERS: 1US FAERS
21Unresponsive to stimuliFAERS: 1US FAERS
22DermatitisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.